丹参川芎联合骨瓜或骨肽对糖尿病骨质疏松患者糖代谢和骨代谢的影响
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

湖北省省卫生计生委中医药科研课题(2016zy16)


Effects of Rhizoma Salvia Miltiorrhiza and Rhizoma Chuanxiong Combined with Bone Melon or Ossotide on Glucose Metabolism and Bone Metabolism in Patients with Diabetic Osteoporosis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨在丹参川芎治疗基础上,结合骨瓜或骨肽应用于糖尿病骨质疏松症对糖代谢、骨代谢作用价值。方法:选取2016年3月至2017年9月湖北省黄石市第二医院受诊的糖尿病骨质疏松症患者253例作为研究对象。将应用丹参川芎结合骨瓜治疗的128例归为骨瓜组,将予以丹参川芎结合骨肽治疗的125例归为骨肽组,分析2组糖化血红蛋白(HbA1c)、空腹血糖(FBG)N-端中段骨钙素(N-MID-OT)、骨特异性碱性磷酸酶(BAP),骨形态发生蛋白-2(BMP-2),骨钙素(BBGP)。骨密度(BMD),甲状旁腺素(PTH)、碱性磷酸酶(ALP),β-胶原特殊序列(β-CTx),并比较药物安全性。结果:1)骨瓜组糖代谢HbA1c(741±064)%、钙离子(221±028)mmol/L、FBG(612±059)mmol/L、血磷(142±025)mmol/L在治疗后与骨肽组HbA1c(779±051)%、钙离子(227±033)mmol/L、FBG(637±083)mmol/L、血磷(135±031)mmol/L差异无统计学意义(P>005);2)骨肽组N-MID-OT(1637±283)ng/mL和骨瓜组差异无统计学意义(P>005),BAP(14226±1066)μg/L、BGP(507±132)μg/L显著低于骨瓜组,BMP-2(8635±624)ng/L显著高于骨瓜组,差异有统计学意义(P<005);3)骨肽组BMD(057±013)g/cm3显著高于骨瓜组,PTH(3226±215)pg/mL、ALP(7235±519)U/L显著低于骨瓜组,差异有统计学意义(P<005),β-CTx(039±002)ng/mL和骨瓜组(042±004)ng/mL差异无统计学意义著(P>005);4)骨瓜组不良反应率(313%)显著低于骨肽组(960%),差异有统计学意义(P<005)。结论:对于糖尿病骨质疏松症的治疗,基于丹参川芎,增加注射用骨肽比较注射用骨瓜提取物,更能促进患者多项骨代谢指标、血清生化指标及BMD的恢复,二者具有相似的调节糖代谢的作用,但骨肽不良反应相对较高,临床上应结合患者实际情况进行药物的选择。

    Abstract:

    To explore the effects of Salvia Rhizoma Miltiorrhiza and Rhizoma Chuanxiong combined with bone melon or Ossotide on glucose metabolism and bone metabolism in patients with diabetic osteoporosis.Methods:From March 2016 to September 2017,253 diabetic patients with osteoporosis treated in The Second Hospital of Huangshi were selected as the study object.The bone melon group included 128 cases treated with Rhizoma Salviae Miltiorrhizae and Rhizoma Chuanxiong,combined with bone melon.The ossotide group included 125 cases treated with Rhizoma Salviae Miltiorrhizae and Rhizoma Chuanxiong,combined with ossotide.The fluctuation of bone metabolism,glucose metabolism and other related biochemical indexes were analyzed before and after treatment.The drug safety was also compared.Results:1)After the treatment,there was no significant difference in glucose metabolism(HbA1c(741±064)%,Ca(221±028)mmol/L,FBG(612±059)mmol/L,P(142±025)mmol/L,HbA1c(779±051)%,Ca(227±033)mmol/L,FBG(637±083)mmol/L,P(135±031)mmol/L)between the bone melon group and the ossotide group(P>005);2)There was no significant difference in N-MID-OT(1637±283)ng/mL between the ossotide group and the bone melon group(P>005),while BAP(14226±1066)μg/L,BGP(507±132)μg/L of the ossotide group were significantly lower than that of the bone melon group,and BMP-2(8635±624)ng/L significantly higher than that of the bone melon group(P<005);3)The BMD(057±013)g/cm3 of the ossotide group was significantly higher than that of the bone melon group,while PTH(3226±215)pg/mL,ALP(7235±519)U/L were significantly lower than that of the bone melon group(P<005); there was no significant difference in β-CTx between the ossotide group(039±002)ng/mL and the bone melon group(042±004)ng/mL(P>005).4)The adverse reaction rate of the bone melon group(313%)was lower than that of the ossotide group(960%)(P<005).Conclusion:For the treatment based on Rhizoma Salviae Miltiorrhizae and Rhizoma Chuanxiong on patients with diabetic osteoporosis,compared to bone melon,the ossotide injection can improve multiple indexes of bone metabolism,serum biochemical indexes and BMD.Both have similar effects in regulating glucose metabolism,but the side effects of ossotide are relatively higher,so it is preferred to select drugs according to individual conditions.

    参考文献
    相似文献
    引证文献
引用本文

孙胜奎,廖建红,范银燕,左丽娜.丹参川芎联合骨瓜或骨肽对糖尿病骨质疏松患者糖代谢和骨代谢的影响[J].世界中医药,2019,(06).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2018-05-31
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-07-08
  • 出版日期:
文章二维码